![Shuli Kulak](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Shuli Kulak
Företagsledare/Principal på
SOLID BIOSCIENCES INC.
Profil
Dr. Shuli Kulak is a Head-Corporate Strategy & Business Development at Solid Biosciences, Inc. Dr. Kulak was previously employed as a Head-Corporate Strategy & Business Development by AavantiBio, Inc. She received her MBA from Sy Syms School of Business and a doctorate degree from Albert Einstein College of Medicine, Inc..
Aktiva positioner av Shuli Kulak
| Företag | Position | Start |
|---|---|---|
| SOLID BIOSCIENCES INC. | Företagsledare/Principal | - |
Tidigare kända positioner av Shuli Kulak
| Företag | Position | Slut |
|---|---|---|
Aavantibio, Inc.
 Aavantibio, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops new gene therapies | Företagsledare/Principal | - |
Shuli Kulaks utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
17
Första gradens relationer
4
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
Albert Einstein College of Medicine, Inc.
 Albert Einstein College of Medicine, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sy Syms School of Business
 Sy Syms School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Solid Biosciences, Inc.
 Solid Biosciences, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that develops treatments through gene therapy for patients with duchenne disease | Health Technology |
Aavantibio, Inc.
Aavantibio, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops new gene therapies | Health Technology |
